| [1] |
CHENG Zhijian, WANG Guoyu, HE Xijing, ZHAI Jingjing, WANG Tiaoning.
NG2 expression in primary culture of bone marrow derived-macrophages and its bioactivity
[J]. Basic & Clinical Medicine, 2026, 46(1): 1-4.
|
| [2] |
LI Binfeng, LYU Fayou, YI Huijun, LYU Lyu.
Advances in the mechanism of action of the ring finger proteins family in breast cancer
[J]. Basic & Clinical Medicine, 2026, 46(1): 124-128.
|
| [3] |
WEI Xinwen, WEN Xiaojun, FAN Zhaoqiang, LAO Xifeng, ZHANG Luqing, ZHONG Ming.
CircAPLP2 inhibits proliferation, migration and invasion of human colorectal cancer cell lines through regulating miR-455-3p/STMN1 axis
[J]. Basic & Clinical Medicine, 2025, 45(9): 1208-1214.
|
| [4] |
AN Xin, JIA Lin, Mawusumu·MAMUT, HUANG Zhipeng, KahrimanI·SLAM, Rexiati·REHEMAN, Hairila·WULAMU, Kerbanjiang·ABULIKIM, Jesur·BATUR.
Effects of ANGPT1 on proliferation,invasion and angiogenesis of mouse prostate cancer cell line RM-1
[J]. Basic & Clinical Medicine, 2025, 45(9): 1165-1172.
|
| [5] |
ZOU Qingbo, ZHANG Guochen, PAN Changjing.
Gypenoside inhibits the proliferation, migration and invasion of prostate cancer cell line PC-3
[J]. Basic & Clinical Medicine, 2025, 45(8): 1059-1065.
|
| [6] |
TIAN Ye, HE Quan, WANG Xiaojuan.
RPRD1B is highly expressed in human ovarian cancer cell lines and promotes tumor cell proliferation
[J]. Basic & Clinical Medicine, 2025, 45(8): 1066-1072.
|
| [7] |
JIN Xiaoxia, LIU Yushan, HU Jiping, ZHU Xinghua.
Expression of COA6 in breast cancer and its correlation with tumor immune cell infiltration
[J]. Basic & Clinical Medicine, 2025, 45(6): 755-761.
|
| [8] |
YIN Lijun, BO Yang, Anggelema, SONG Linlin.
LncRNA HIF1A-AS1 promotes the proliferation of gastric cancer cell lines through interfering with HIF1A
[J]. Basic & Clinical Medicine, 2025, 45(5): 627-636.
|
| [9] |
WANG Meng, SHEN Xuejing, LIU Jia, SHANG Lulu, ZHANG Mo.
Probe-based label-free SERS for identification of breast cancer-induced serum metabolic profiles in patients
[J]. Basic & Clinical Medicine, 2025, 45(5): 651-657.
|
| [10] |
ZHANG Ke, LU Jiangning, SUN Lixin, YU Long, SUN Lichao, RAN Yuliang.
TOMM40L promotes proliferation and migration of triple negative breast cancer cells and correlates with poor prognosis
[J]. Basic & Clinical Medicine, 2025, 45(5): 575-582.
|
| [11] |
WEI Jianxin, FANG Yanle, LU Yubo, GAO Yuguang, LANG Xing, LI Jingtao, MA Xinsheng.
Artesunate inhibits proliferation and promotes apoptosis and autophagy of nephroblastoma cell line SK-NEP-1
[J]. Basic & Clinical Medicine, 2025, 45(4): 493-498.
|
| [12] |
ZHOU Jing, QU Miao.
Upregulation of miR-152 inhibits proliferation and migration of human vascular smooth muscle cells induced by ox-LDL
[J]. Basic & Clinical Medicine, 2025, 45(4): 486-492.
|
| [13] |
LUO Yubei, HUANG Jianjun, YANG Wenxiu, ZHANG Junhong, LI Jing, Robert Chunhua ZHAO, DOU Xiaowei.
Establishment and preliminary study of four patient-derived primary breast cancer cell lines
[J]. Basic & Clinical Medicine, 2025, 45(2): 183-188.
|
| [14] |
ZHANG Yao, ZHANG Xuan, JIA Anna, ZHAN Shijia, GUO Jinxin, CHANG Yan, GUO Yongli.
Olfactory domain family protein 3 promotes the proliferation of MYCN-amplified neuroblastoma cell lines in vitro
[J]. Basic & Clinical Medicine, 2025, 45(2): 168-175.
|
| [15] |
ZHANG Yanchi, SHI Junqi, ZHANG Yijun, DUAN Jiawen, LIU Jinyu, ZHANG Liyan, LIANG Wanping.
Advances in synergistic therapies targeting metabolic mechanisms and the immune microenvironment in breast cancer
[J]. Basic & Clinical Medicine, 2025, 45(12): 1662-1667.
|